Study on Preventing Anemia in Children in Ghana
This study has been completed.
Sponsor:
Ghana Health Services
Collaborator:
Netherlands Overseas Agency
Information provided by:
Ghana Health Services
ClinicalTrials.gov Identifier:
NCT00301054
First received: March 9, 2006
Last updated: May 26, 2006
Last verified: July 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A study that seeks to establish an effective way of preventing anaemia in children at the community level using two known interventions - Iron supplementation and or antimalarial. Children recruited into the study will be assigned to four groups. Those receiving Placebo and Iron, those receiving Placebo and Antimalarial, those receiving Placebo and Antimalarial and those receiving double placebo. The children will be followed up over a period of nine months and their haemoglobin concentration, malaria parasites in their blood and their weight and height will be assessed.
| Condition | Intervention |
|---|---|
|
Anaemia in Children |
Drug: Ferrous sulphate Drug: Sulphadoxine-Pyrimethamine |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Factorial Assignment Masking: Double-Blind Primary Purpose: Prevention |
| Official Title: | Preventing Anemia in Children (6months-30months) in a Malaria Endemic Rural Area in Ghana - A Randomized Double Blind Study |
Resource links provided by NLM:
Further study details as provided by Ghana Health Services:
Primary Outcome Measures:
- Haemoglobin concentration, Blood Film for malaria parasitaemia, weight/height ratio
Secondary Outcome Measures:
- Incidence of vaccine preventable diseases like measles whooping cough(pertussis)
| Estimated Enrollment: | 872 |
| Study Start Date: | June 2005 |
| Estimated Study Completion Date: | April 2006 |
Show Detailed Description Eligibility| Ages Eligible for Study: | 6 Months to 30 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- All children living in Berekum District who are between 6months- 30months
Exclusion Criteria:
- All Children living in Berekum District between 6months- 30months who are G6PD Deficient
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00301054
Locations
| Ghana | |
| District Health Directorate | |
| Berekum, Brong- Ahafo, Ghana | |
Sponsors and Collaborators
Ghana Health Services
Netherlands Overseas Agency
Investigators
| Principal Investigator: | ANTHONY A OFOSU, MBChB, MPH | GHANA HEALTH SERVICE BEREKUM DISTRICT |
| Study Director: | DONNA M DENNO, MD, PAEDS | UNIVERSITY OF WASHINGTON MEDICAL CENTER, SEATTLE, USA |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00301054 History of Changes |
| Other Study ID Numbers: | 2003/GD/23 |
| Study First Received: | March 9, 2006 |
| Last Updated: | May 26, 2006 |
| Health Authority: | Ghana: Ministry of Health |
Keywords provided by Ghana Health Services:
|
Anaemia Malaria Rural Area in Ghana |
Additional relevant MeSH terms:
|
Anemia Hematologic Diseases Pyrimethamine Sulfadoxine Sulfadoxine-pyrimethamine Antimalarials Antiprotozoal Agents Antiparasitic Agents |
Anti-Infective Agents Therapeutic Uses Pharmacologic Actions Folic Acid Antagonists Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Anti-Infective Agents, Urinary Renal Agents |
ClinicalTrials.gov processed this record on June 18, 2013